63 Overall, the authors suggested that potential non-TJal functions of claudin-7, including maintenance of epithelial cellmatrix interactions and intestinal homeostasis, may be responsible for the phenotype observed in claudin-7-null mice
A label saying research use only does not make a product approved, clinically validated, or safe for personal use
supports insulin sensitivity Nervous System: Protects against neurodegeneration and cognitive decline Skin: Improves autoimmune conditions and accelerates wound healing Future Applications of GLP-1 Medications As clinical trials continue, GLP-1 receptor agonists may soon be approved for: Neurodegenerative diseases: Alzheimers, Parkinsons, MS Autoimmune conditions: Psoriasis, RA, Lupus Cardiometabolic syndromes: NAFLD, PCOS, atherosclerosis Pulmonary conditions: Chronic bronchitis, COPD, even long-COVID inflammation Final Thoughts GLP-1 medications are no longer just diabetes or weight loss drugs
doi: 10.1111/ijpo.70024
Beyond being frustrating on a personal level, those changes can create tension, confusion, and stress in even the strongest relationships
